IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
University of Pittsburgh
Fate Therapeutics
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
AstraZeneca
Neonc Technologies, Inc.
Brown University
Rakuten Medical, Inc.
Nurix Therapeutics, Inc.
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Michigan Rogel Cancer Center
Iovance Biotherapeutics, Inc.
Akeso
Fudan University
Lyvgen Biopharma Holdings Limited